Last reviewed · How we verify
urinary hCG (u-hCG) — Competitive Intelligence Brief
phase 3
Gynecology
Small molecule
Live · refreshed every 30 min
Target snapshot
urinary hCG (u-hCG) (urinary hCG (u-hCG)) — Merck KGaA, Darmstadt, Germany. Urinary hCG is a diagnostic test that detects the presence of human chorionic gonadotropin in urine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| urinary hCG (u-hCG) TARGET | urinary hCG (u-hCG) | Merck KGaA, Darmstadt, Germany | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- urinary hCG (u-hCG) CI watch — RSS
- urinary hCG (u-hCG) CI watch — Atom
- urinary hCG (u-hCG) CI watch — JSON
- urinary hCG (u-hCG) alone — RSS
Cite this brief
Drug Landscape (2026). urinary hCG (u-hCG) — Competitive Intelligence Brief. https://druglandscape.com/ci/urinary-hcg-u-hcg. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing